Quarter Financials
Bristol-Myers Squibb Company (BMY)
$67.14
-0.10 (-0.15%)
Income Statement
Balance Sheet
Cash Flow
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
Net Income | 2,022 | 1,606 | 1,421 | 1,278 | 2,372 | 1,546 | 1,055 | 2,021 |
Dividend Paid | -1,145 | -1,154 | -1,150 | -1,185 | -1,099 | -1,090 | -1,099 | -1,108 |
Retained Earnings | 25,503 | 24,675 | 24,217 | 23,948 | 23,820 | 22,625 | 22,168 | 22,204 |
---|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
Capital Expenditure | -346 | -247 | -272 | -253 | -320 | -270 | -210 | -173 |
Net PPE | 6,255 | 6,035 | 6,810 | 6,941 | 6,968 | 6,835 | 6,801 | 6,613 |
---|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
New Purchases | -1,302 | -1,041 | -1,065 | -2,070 | -1,714 | -1,578 | -274 | -26 |
Intangible and Goodwill | 20,524 | 20,529 | 20,519 | 20,502 | 20,500 | 20,446 | 21,112 | 21,149 |
---|